Skip to content

Search Results

No Matching Results

    Recently Viewed


      HomeMedia CenterPress releases Medical technologiesNew Onetouch Verio Flex™ Blood Glucose Monitoring System with ColorSure™ Technology Takes the Guesswork Out of Blood Sugar Test Results

      New Onetouch Verio Flex™ Blood Glucose Monitoring System with ColorSure™ Technology Takes the Guesswork Out of Blood Sugar Test Results

      -- 9 out of 10 People With Diabetes Agree The System’s Simple Color Range Indicator Helps Them Easily Interpret Their Blood Sugar Readings --

      Share Article
      share to

      WAYNE, PA (February 24, 2016) – LifeScan, Inc. has introduced the new OneTouch Verio Flex blood glucose monitoring system, with ColorSure™ technology – a simple, accurate and easy-to-use meter that takes the guesswork out of understanding blood sugar test results for people with diabetes. Its simple color range indicator uses color to instantly tell patients when their blood glucose readings are “low,” “in range,” or “high” so they can quickly get on with their lives. Nine out of 10 people with diabetes agreed that the meter’s color range indicator helped them easily interpret their blood sugar readings. While it has broad appeal as a simple, intuitive meter on its own, patients can also use the meter’s built-in Bluetooth® Smart Technology to wirelessly connect with the companion OneTouch Reveal® mobile app available on compatible iOS and Android mobile devices.

      “Research shows that ease of use remains a very important reason for meter selection by a majority of patients while, at the same time, one third say they can’t make sense of their blood sugar results,” said Dr. Jeremy Pettus, Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego. “The new OneTouch Verio Flex meter is designed to help people with diabetes better understand and manage their blood glucose. It provides basic information when all they want to know is their number and if they’re in range; while the mobile app provides key insights and information sharing if they’re interested in more.”

      The low and high range limits set in the OneTouch Verio Flex™ meter can be customized for each patient based on their healthcare professional’s recommendations. With each test, the simple color range indicator shows whether a result is below limit (blue), within range (green) or above the limit (red). Nine out of 10 healthcare professionals agreed that knowing when their readings are in or out of range may help patients reach their blood sugar goals and stay in better control.

      Currently, there are an estimated 29 million people with diabetes in the US and many don’t test their blood sugar regularly or as recommended by their healthcare professional. Seven out of 10 people with diabetes agreed that the OneTouch Verio Flex meter with its simple color range indicator could encourage them to test as recommended.

      Key features of the OneTouch Verio Flex™ system include:

      • Slim, compact design with large, easy-to-read numbers
      • Simple color range indicator makes it easy to immediately see if a blood sugar result is in or out of range
      • 500-test result memory with date and time
      • Uses OneTouch Verio® Test Strips that require only a small amount of blood (0.4 ul) and offer easy application to either side of the test strip
      • Bluetooth® Smart Technology connectivity with the OneTouch Reveal® mobile app on iOS and Android devices
      • Uses one CR2032 lithium coin cell battery

      The OneTouch Verio Flex™ meter is the latest addition to the OneTouch Verio® product family that also includes:

      • The OneTouch Verio® meter that gives patients helpful information and feedback at a glance;
      • The OneTouch Verio®IQ meter that spots patterns and helps patients understand how insulin, meals and lifestyle affect their numbers.

      While each meter provides unique benefits, they all use the same OneTouch Verio® test strips for accurate results and offer unsurpassed insurance coverage.1

      LifeScan has begun shipping the new OneTouch Verio Flex system to retailers and it will soon be available nationally wherever diabetes testing supplies are sold with an estimated retail price of $19.99. OneTouch® is the most recommended brand by endocrinologists and primary care physicians. OneTouch® test strips have the lowest co-pay on the most health plans2 and could save users $40 a month.3 In addition, OneTouch® test strips are always covered by Medicare Part B.4 For more information about the OneTouch Verio Flex™ meter and other OneTouch® products, visit

      About LifeScan, Inc.

      LifeScan, Inc. is part of the Johnson & Johnson Diabetes Care Companies. With a shared vision of creating a world without limits for people with diabetes, the Johnson & Johnson Diabetes Care Companies is a collaboration of Johnson & Johnson companies dedicated to diabetes and includes LifeScan, Inc., a world leader in blood glucose monitoring; Animas Corporation, maker of innovative insulin delivery systems; and Calibra Medical, Inc., developer of a unique 3-day wearable insulin patch pump. In the US, LifeScan, Inc. is the leading maker of blood glucose monitoring systems and its OneTouch® brand products are recommended by more endocrinologists and primary care physicians than any other brand. Globally, more than 10 million people depend on OneTouch® brand products for simple testing and accurate results to help them manage their diabetes. For more information visit:


      LifeScan, Inc.
      Dave Detmers

      Marston Strategic Communications
      Lara Markenson
      Mike Cargill

      Cautions Concerning Forward-Looking Statements

      This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the new OneTouch Verio Flex™ blood glucose monitoring system. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of LifeScan, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; product efficacy or safety concerns resulting in product recalls or regulatory action; manufacturing difficulties and delays; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended December 28, 2014, including in Exhibit 99 thereto, and the company’s subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at, or on request from Johnson & Johnson. Neither LifeScan, Inc. nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.

      1. OneTouch® brand test strips have the lowest co-pay on the most health plans. Some health plans might cover more than one test strip at the lowest co-pay.

      2. Some health plans might cover more than one test strip at the lowest co-pay.

      3. Co-pay savings is based on average co-pay differential between preferred and nonpreferred tiers.

      4. Not a guarantee of coverage and payment. Coverage and payment may be subject to co-insurance, deductible, and patient eligibility requirements.

      Dr. Pettus is a paid consultant for LifeScan, Inc.

      The Bluetooth® Smart word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by LifeScan is under license.

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.